Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wasserman

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|July 1, 1988
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkeyD P Brooks, P F Koster, F L Stassen, et al.
Journal of Environmental Radioactivity|October 2, 2007
Soil to plant transfer of 137Cs and 60Co in Ferralsol, Nitisol and AcrisolM A Wasserman, F Bartoly, A G Viana, et al.
Journal of Environmental Radioactivity|October 2, 2007
The effect of organic amendment on potential mobility and bioavailability of 137Cs and 60Co in tropical soilsM A Wasserman, F Bartoly, A P Portilho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dogG A Kopia, R E Valocik, T J Torphy, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analogB M Weichman, M A Wasserman, D A Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxisM O'Donnell, R J Garippa, N Rinaldi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studiesM O'Donnell, R J Garippa, N Rinaldi, et al.
Biochemical and Biophysical Research Communications|December 28, 1983
2-nor-leukotriene analogs: antagonists of the airway and vascular smooth muscle effects of leukotriene C4, D4 and E4J G Gleason, T W Ku, M E McCarthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienesT J Torphy, J F Newton, M A Wasserman, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1987
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airwaysD W Hay, R M Muccitelli, S S Tucker, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|July 1, 1988
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkeyD P Brooks, P F Koster, F L Stassen, et al.
Journal of Environmental Radioactivity|October 2, 2007
Soil to plant transfer of 137Cs and 60Co in Ferralsol, Nitisol and AcrisolM A Wasserman, F Bartoly, A G Viana, et al.
Journal of Environmental Radioactivity|October 2, 2007
The effect of organic amendment on potential mobility and bioavailability of 137Cs and 60Co in tropical soilsM A Wasserman, F Bartoly, A P Portilho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dogG A Kopia, R E Valocik, T J Torphy, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analogB M Weichman, M A Wasserman, D A Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxisM O'Donnell, R J Garippa, N Rinaldi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studiesM O'Donnell, R J Garippa, N Rinaldi, et al.
Biochemical and Biophysical Research Communications|December 28, 1983
2-nor-leukotriene analogs: antagonists of the airway and vascular smooth muscle effects of leukotriene C4, D4 and E4J G Gleason, T W Ku, M E McCarthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienesT J Torphy, J F Newton, M A Wasserman, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1987
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airwaysD W Hay, R M Muccitelli, S S Tucker, et al.
Pageof 8